Improper WBC differential unreliable for detecting meningococcal disease
Click Here to Manage Email Alerts
Automated methods that do not measure immature white blood cell counts should be avoided when assessing febrile children for meningococcal infection, according to recent study findings published in The Pediatric Infectious Disease Journal.
“Automated blood cell counts that do not measure bands will frequently be falsely reassuring in children with invasive meningococcal disease,” researchers wrote. Band counts allow “determination of [absolute neutrophil count], [immature neutrophil count], and [immature-to-total neutrophil ratio], which together are useful whenever blood cell counts are ordered for assessment of children with fever, to aid in the early identification of invasive bacterial infections including meningococcal disease.”
The study included 216 patients aged 1 month to 20 years (60.6% were aged younger than 4 years) using a data set previously collected from 2001 to 2011 by the US Multicenter Meningococcal Surveillance Study. White blood cell count (WBC), absolute neutrophil count, immature neutrophil count and immature-to-total neutrophil ratio were evaluated alone and in combination at diagnosis of invasive meningococcal disease.
Researchers found that 23.6% of the patients required mechanical ventilation, and 6.9% died. Taken individually, absolute neutrophil count ≤1,000/mm3 or ≥10,000/mm3 was found in 63.4% of participants, immature neutrophil count ≥500/mm3 in 78.7%, and immature-to-total neutrophil ratio ≥0.20 in 64.4%.
When taken in combination, however, they also found that one or more of the absolute neutrophil count, immature neutrophil count, or immature-to-total neutrophil ratio met these abnormal criteria in 94.4% of all cases. Notably, however, total WBC was normal in 33.3%.
“This is practical importance, since it indicated reliance on total WBC and total neutrophil count alone would have been falsely reassuring,” researchers wrote. “In addition, even slightly abnormal total WBC did not add any additional positive cases to those meeting with one of the other criteria.”
Disclosure: The study was funded in part by Sanofi-Pasteur.